scorecardresearch
Business Today
Subscribe
Immersives UPSTART G20 Summit Corporate Petrol-Diesel Weather BT Bazaar
BT 100 BT Accenture PwC De-risking the Future BT-TR GCC Listing
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
News
Markets
Stocks
Auro Laboratories Ltd

Feedback
Auro Laboratories Ltd

Auro Laboratories Ltd Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 6,064
Sep 14, 2023 16:01 IST-
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹114.65
₹0.85 (0.83%)
    Powered By :
₹111 Low
Today’s Performance
₹119 High
₹52.5 Low
52 Week’s Performance
₹150.75 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -0.83%
  • 1 Week -8.10%
  • 1 Month 46.94%
  • 3 Months 28.40%
  • 6 Months 82.02%
  • 1 Year 29.71%
  • 3 Years 25.06%
  • 5 Years 7.30%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 10.00
  • Beta 0.03
  • 52-Week Low (₹) 52.50
  • 52-Week High (₹) 150.75
  • Price-to-Book (X)* 2.06
  • Dividend Yield (%) 0.00
  • Price-to-Earnings (P/E) (X)* 22.94
  • Earnings Per Share (₹) 4.92
  • Sector Price Earning (X)* 33.20
  • Market Cap (₹ Cr.)* 70.31
  • * Vaues as of last close price

COMPETITORS

BT TV

thumb 39:53 Historic India-Middle East-Europe Corridor Puts China On Notice
THUMB 5:05 Delhi Tops In Terms Of Electric Buses After Arvind Kejriwal Govt Introduces 400 New Buses
thumb 4:42 The India-Middle East-Europe Corridor: A Counter To China's Belt & Road Initiative
THUMB 4:04 Putin Praises Modi’s ‘Make In India’, Cites Example To Russian Auto Industry
THUMB 9:44 Tata Motors' Electrifying Future: In Conversation With Shailesh Chandra On EV Expansion
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

No Data For Block Deal.

*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Aug 31, 2023 PURCHASE
AUROLAB ,PADRONE MARKETING PVT LTD
  • Qty 50000
  • Average Price ₹134.87
Jun 30, 2023 Sell
AUROLAB ,AMIT DHANYAKUMAR CHORDIA
  • Qty 31240
  • Average Price ₹80.78
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

FAQ’S

What was Auro Laboratories Ltd share price previously?
Auro Laboratories Ltd share price was up by -0.83% from the previous closing price of ₹113.80.
Who are peers of Auro Laboratories Ltd?
The peers of Auro Laboratories Ltd are Glenmark Pharmaceuticals Ltd, Gland Pharma Ltd, Lupin Ltd, Aurobindo Pharma Ltd, Glaxosmithkline Pharmaceuticals Ltd, Sun Pharmaceuticals Industries Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Divis Laboratories Ltd, Biocon Ltd, Zydus Lifesciences Ltd, Syngene International Ltd, Alkem Laboratories Ltd.
Who is/are the promoter/promoters of Auro Laboratories Ltd?
The promotor/promotors of Auro Laboratories Ltd are Sharat Deorah, Siddhartha Deorah, Goverdhandas Aggarwal, Kailash Chandra Bubna, Kavita Vijayakant Sharma, Kiran Kulkarni, Sweta Agarwal.
What has been 52-week high of Auro Laboratories Ltd stocks?
The highest price of Auro Laboratories Ltd stock is ₹150.75 in the last 52-week.
What is the share price of Auro Laboratories Ltd () today on BSE?
As on Sep 14, 2023, Auro Laboratories Ltd ()’s share price on BSE is Rs 114.65
What is the market cap of Auro Laboratories Ltd (?)
The current market capitalisation of Auro Laboratories Ltd () is 70.31 crores
What is Auro Laboratories Ltd Share symbol?
The symbol of Auro Laboratories Ltd is .
What is the PE ratio of Auro Laboratories Ltd ()?
The current PE ratio of Auro Laboratories Ltd () is 22.94.
What is the PB ratio of Auro Laboratories Ltd ()?
The current PB ratio of Auro Laboratories Ltd () is 2.06.
Today’s High & Low share prices of Auro Laboratories Ltd () on BSE?
Today, the share price of Auro Laboratories Ltd () on BSE touched a high of Rs 119 and a low of Rs 111
What price did Auro Laboratories Ltd () shares open on the BSE today?
On BSE, the share price of Auro Laboratories Ltd () opened at Rs 114
What is the 52-week high of Auro Laboratories Ltd ()?
The 52-week high price of Auro Laboratories Ltd () is Rs 150.75
What is the 52-week low of Auro Laboratories Ltd () ?
The 52-week low price of Auro Laboratories Ltd () is Rs 52.5

ABOUT AURO LABS.

Auro Laboratories Ltd, incorporated in the year 1989, has its registered office in K-56 MIDC Indl Area, Tarapur Boisar, Thane, Maharashtra, 401506, 91-22-66635456. The main industry in which Auro Laboratories Ltd operates is Pharmaceuticals - Indian - Bulk Drugs.

Auditor/Auditors for Auro Laboratories Ltd is/are Khurdia Jain & Co. In the main management, Sharat Deorah is chairman and Sweta Agarwal is the company secretary for Auro Laboratories Ltd.

  • SD Sharat Deorah Chairman & Managing Director
  • SD Siddhartha Deorah Whole-time Director
  • GA Goverdhandas Aggarwal Independent Director
  • KCB Kailash Chandra Bubna Independent Director
  • KVS Kavita Vijayakant Sharma Independent Director
  • KK Kiran Kulkarni Whole-time Director
  • SA Sweta Agarwal Company Sec. & Compli. Officer

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.